1. Home
  2. JJSF vs VIR Comparison

JJSF vs VIR Comparison

Compare JJSF & VIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo J & J Snack Foods Corp.

JJSF

J & J Snack Foods Corp.

HOLD

Current Price

$89.47

Market Cap

1.4B

ML Signal

HOLD

Logo Vir Biotechnology Inc.

VIR

Vir Biotechnology Inc.

HOLD

Current Price

$9.24

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
JJSF
VIR
Founded
1971
2016
Country
United States
United States
Employees
1800
N/A
Industry
Specialty Foods
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.5B
IPO Year
1995
2019

Fundamental Metrics

Financial Performance
Metric
JJSF
VIR
Price
$89.47
$9.24
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
7
Target Price
$140.00
$19.43
AVG Volume (30 Days)
239.7K
1.5M
Earning Date
05-06-2026
05-06-2026
Dividend Yield
3.67%
N/A
EPS Growth
N/A
17.49
EPS
1.99
N/A
Revenue
$1,022,038,000.00
$68,556,000.00
Revenue This Year
$0.30
$270.22
Revenue Next Year
$1.70
N/A
P/E Ratio
$45.73
N/A
Revenue Growth
N/A
N/A
52 Week Low
$68.87
$4.25
52 Week High
$116.32
$11.66

Technical Indicators

Market Signals
Indicator
JJSF
VIR
Relative Strength Index (RSI) 65.76 51.93
Support Level $80.49 $8.43
Resistance Level $96.42 $9.80
Average True Range (ATR) 2.80 0.40
MACD 0.90 0.04
Stochastic Oscillator 82.79 58.10

Price Performance

Historical Comparison
JJSF
VIR

About JJSF J & J Snack Foods Corp.

J&J Snack Foods Corp. manufactures snack foods and distributes frozen beverages, which it markets nationally to the foodservice and retail supermarket industries. The company's portfolio of frozen beverages, frozen novelties, and baked goods includes soft pretzels, frozen juice treats and desserts, stuffed sandwiches, churros, funnel cakes, cookies, and other snack foods and drinks. It operates through three segments: Food Service, which sells snacks, desserts, and baked goods at the point of sale; Retail Supermarkets, which sells frozen and prepackaged products to supermarkets; and Frozen Beverages, which sells frozen beverages under the ICEE, Slush Puppie, and Parrot Ice brands in the United States, Mexico, and Canada. The majority of revenue comes from the Food Service segment.

About VIR Vir Biotechnology Inc.

Vir Biotechnology Inc is a clinical-stage biopharmaceutical company focused on powering the immune system by discovering and developing medicines for serious infectious diseases and cancer. The company uses its capabilities in antibody discovery and engineering, coupled with its proprietary AI engine dAIsY system, and the PRO-XTEN masking platform, to quickly and effectively discover and optimize potential new medicines. Its clinical development pipeline consists of investigational therapies like Tobevibart + elebsiran targeting the hepatitis delta virus (HDV), preclinical antibody candidates targeting HIV, and VIR-5500, VIR-5818, VIR-5525, and 7 PRO-XTEN programs targeting multiple solid tumors. Currently, the company generates revenue mainly by issuing license rights and through grants.

Share on Social Networks: